Viral Early Detection LIS Code: SH19
Get early detection of Hepatitis B, Hepatitis C, and HIV with the Viral Early Detection Profile at Vitalync Diagnosis. PCR technology ensures accurate, fast results for early treatment.
What's included in this profile
- Directly detects HIV genetic material in the blood
- Used for very early detection or to confirm infection
- More sensitive than antibody testing in the earliest stages
- Directly measures the amount of Hepatitis B virus in the blood
- Used to monitor disease activity and treatment response
- More precise than antigen/antibody testing alone
- Directly detects Hepatitis C virus in the blood
- Confirms whether an infection is currently active
- Used to guide and monitor treatment
About this profile
The Viral Early Detection Profile (PCR) is an advanced blood test that uses polymerase chain reaction (PCR) technology to detect viral genetic material at the earliest stages of infection. This highly sensitive test identifies the presence of Hepatitis B (HBV), Hepatitis C (HCV), and Human Immunodeficiency Virus (HIV) in the bloodstream before antibodies or symptoms appear, ensuring rapid and precise diagnosis.
Who is this profile for?
This test is recommended for individuals who:
– Have had potential exposure to HBV, HCV, or HIV through unprotected sex, shared needles, or contact with infected blood.
– Believe they may have recently been exposed and require early detection before antibodies develop.
– Are pregnant, to safeguard maternal and fetal health.
– Work in healthcare or other high-risk environments with exposure to bloodborne pathogens.
– Are living with HBV, HCV, or HIV and require viral load monitoring for treatment management.
What can be detected
Hepatitis B Virus (HBV):
Detects the presence of HBV DNA, confirming active infection even in the early stages. Early detection supports effective treatment and helps prevent serious complications such as liver cirrhosis or hepatocellular carcinoma.
Hepatitis C Virus (HCV):
Identifies HCV RNA in the blood, indicating an active infection before antibodies are detectable. Early diagnosis enables timely antiviral therapy and significantly reduces the risk of chronic liver disease.
Human Immunodeficiency Virus (HIV):
Detects HIV RNA directly from the bloodstream. This method identifies infection earlier than antibody-based tests, allowing for prompt initiation of antiretroviral therapy to prevent disease progression and transmission.
Fasting requirements
No fasting is required for this test. You can continue normal food and fluid intake before sample collection.
